Clinical Manufacturing of Regulatory T Cell Products For Adoptive Cell Therapy and Strategies to Improve Therapeutic Efficacy

ABSTRACTBased on successes in preclinical animal transplant models, adoptive cell therapy (ACT) with regulatory T cells (Tregs) is a promising modality to induce allograft tolerance or reduce the use of immunosuppressive drugs to prevent rejection. Extensive work has been done in optimizing the best...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kassandra J. Baron, Hēth R. Turnquist
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2023-12-01
Saila:	Organogenesis
Gaiak:	Regulatory T cells GMP manufacturing ex vivo expansion solid organ transplant immunotherapy
Sarrera elektronikoa:	https://www.tandfonline.com/doi/10.1080/15476278.2022.2164159
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!